Julie Decock
Julie Decock
scientist, Qatar Biomedical Research Institute, Doha Qatar
Verified email at qf.org.qa - Homepage
Cited by
Cited by
Matrix metalloproteinases: protective roles in cancer
J Decock, S Thirkettle, L Wagstaff, DR Edwards
Journal of cellular and molecular medicine 15 (6), 1254-1265, 2011
Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis
J Decock, JR Long, RC Laxton, XO Shu, C Hodgkinson, W Hendrickx, ...
Cancer research 67 (21), 10214-10221, 2007
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive
B Van Calster, IV Bempt, M Drijkoningen, N Pochet, J Cheng, ...
Breast cancer research and treatment 113 (1), 181-187, 2009
Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis
J Decock, W Hendrickx, U Vanleeuw, V Van Belle, S Van Huffel, ...
BMC cancer 8 (1), 77, 2008
NY-ESO-1 based immunotherapy of cancer: current perspectives
R Thomas, G Al-Khadairi, J Roelands, W Hendrickx, S Dermime, ...
Frontiers in immunology 9, 947, 2018
The roles of ADAMTS metalloproteinases in tumorigenesis and metastasis
L Wagstaff, R Kelwick, J Decock, DR Edwards
Front Biosci 16 (1), 1861-1872, 2011
Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer
J Decock, N Obermajer, S Vozelj, W Hendrickx, R Paridaens, J Kos
The International journal of biological markers 23 (3), 161-168, 2008
Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer
J Decock, R Paridaens, S Ye
Clinical genetics 73 (3), 197-211, 2008
Matrix metalloproteinase 8 (collagenase 2) induces the expression of interleukins 6 and 8 in breast cancer cells
S Thirkettle, J Decock, H Arnold, CJ Pennington, DM Jaworski, ...
Journal of Biological Chemistry 288 (23), 16282-16294, 2013
Immunogenomic classification of colorectal cancer and therapeutic implications
J Roelands, PJK Kuppen, L Vermeulen, C Maccalli, J Decock, E Wang, ...
International journal of molecular sciences 18 (10), 2229, 2017
TGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2
SK Leivonen, K Lazaridis, J Decock, A Chantry, DR Edwards, VM Kähäri
PLoS One 8 (2), e57474, 2013
Proteases and metastasis: clinical relevance nowadays?
J Decock, R Paridaens, T Cufer
Current opinion in oncology 17 (6), 545-550, 2005
Metalloproteinase‐dependent and‐independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and …
R Kelwick, L Wagstaff, J Decock, C Roghi, LS Cooley, SD Robinson, ...
International journal of cancer 136 (4), E14-E26, 2015
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas
J Decock, W Hendrickx, M Drijkoningen, H Wildiers, P Neven, A Smeets, ...
Disease markers 23 (3), 189-196, 2007
Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variables
J Decock, W Hendrickx, H Wildiers, MR Christiaens, P Neven, ...
Clinical & experimental metastasis 22 (6), 495-502, 2005
Pleiotropic functions of the tumor-and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice
J Decock, W Hendrickx, S Thirkettle, A Gutiérrez-Fernández, ...
Breast Cancer Research 17 (1), 38, 2015
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors
O Brouckaert, S Pintens, V Van Belle, S Van Huffel, E Camerlynck, ...
Breast cancer research and treatment 115 (2), 349-358, 2009
Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer
P Neven, B Van Calster, I Van den Bempt, S Van Huffel, V Van Belle, ...
Breast cancer research and treatment 110 (1), 153-159, 2008
The MAPK hypothesis: immune-regulatory effects of MAPK-pathway genetic dysregulations and implications for breast cancer immunotherapy
D Bedognetti, J Roelands, J Decock, E Wang, W Hendrickx
Emerging Topics in Life Sciences 1 (5), 429-445, 2017
Immune checkpoints in the tumor microenvironment
SM Toor, VS Nair, J Decock, E Elkord
Seminars in cancer biology, 2019
The system can't perform the operation now. Try again later.
Articles 1–20